PDCD1 and myelodysplastic syndrome: In addition, the negative co-stimulatory T-cell receptor programmed cell death-1 (PD-1) and its ligands, PD-L1 and PD-L2, were found to be overexpressed in the progression from lower to higher risk MDS [17,18].